Compare DRTS & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRTS | NBN |
|---|---|---|
| Founded | 2015 | 1872 |
| Country | Israel | United States |
| Employees | N/A | 234 |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2021 | N/A |
| Metric | DRTS | NBN |
|---|---|---|
| Price | $14.67 | $134.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $130.50 |
| AVG Volume (30 Days) | ★ 576.3K | 81.1K |
| Earning Date | 05-18-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.03% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.77 |
| Revenue Next Year | $699.98 | $18.72 |
| P/E Ratio | ★ N/A | $11.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.43 | $80.75 |
| 52 Week High | $15.17 | $142.31 |
| Indicator | DRTS | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 53.40 |
| Support Level | $13.65 | $127.84 |
| Resistance Level | $15.01 | $137.72 |
| Average True Range (ATR) | 0.65 | 3.27 |
| MACD | -0.10 | 0.33 |
| Stochastic Oscillator | 49.34 | 75.98 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The bank conducts its loan-related activities through two primary channels: the National Lending Division and the Small Business Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans; consumer loans; and small business administration loans, among others. Additionally, the bank provides telephone banking, online banking, mobile banking, and remote deposit capture services, and other banking products and services. The majority of its revenue is derived in the form of interest and dividends.